This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feldman, M. D. Articles by Kass, D. A. Search for Related Content PubMed PubMed Citation Articles by Feldman, M. D. Articles by Kass, D. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cardiomyopathy

(Circulation. 1996;93:474-483.)
© 1996 American Heart Association, Inc.

Articles

Acute Cardiovascular Effects of OPC-18790 in Patients With Congestive Heart Failure

Time- and Dose-Dependence Analysis Based on Pressure-Volume Relations

Marc D. Feldman, MD; Peter H. Pak, MD; Clarence C. Wu, MS; Howard L. Haber, MD; Christian M. Heesch, MD; James D. Bergin, MD; Eric R. Powers, MD; T. Douglas Cowart, PhD; William Johnson, RN; Arthur M. Feldman, MD, PhD; David A. Kass, MD

From the Divisions of Cardiology and the Departments of Internal Medicine, the Johns Hopkins Medical Institutions, Baltimore, Md, and the University of Virginia Health Sciences Center, Charlottesville.

Correspondence to David A. Kass, MD, Division of Cardiology, Halsted 500, Johns Hopkins University Hospital, 600 N Wolfe St, Baltimore, MD 21287.

Background OPC-18790 is a water-soluble quinolinone derivative that shares the pharmacological properties of vesnarinone and that may be useful for treating heart failure. We studied the contribution and relative dose sensitivities of the inotropic, lusitropic, and vascular effects of OPC-18790 in patients with dilated cardiomyopathy.

Methods and Results Pressure-volume (PV) analysis was performed in 17 patients who received either 5 µg·kg^-1·min^-1 (low dose, n=10) or 10 µg·kg^-1·min^-1 (high dose, n=7) OPC-18790 by 1-hour IV infusion. Right heart pressures and flow and left heart PV relations (conductance catheter) were measured at baseline and every 15 minutes during infusion. Transient inferior vena caval obstruction was used to determine PV relations. Both doses produced venodilation reflected by a 10% decline in left ventricular end-diastolic volume and a 30% fall in atrial and pulmonary artery pressures. Arterial dilation was four times greater at the high dose, with an 40% fall in effective arterial elastance and systemic resistance. Contractility rose by 25% to 100% (depending on PV index) with both doses. Ventricular-arterial coupling (ratio of ventricular end-systolic to arterial elastances) was 0.25 at baseline and doubled (or tripled) at low (or high) dose, correlating with improved efficiency. Isovolumetric relaxation shortened, whereas the diastolic PV relation was generally unchanged. Heart rate was unaltered.

Conclusions OPC-18790 has potent venous and arterial vasodilator effects and moderate inotropic and lusitropic effects without a change in heart rate. These combined actions suggest a unique potential of OPC-18790 for heart failure treatment.

Key Words: cardiomyopathy • inotropic agents • heart failure • hemodynamics • quinolinone

This article has been cited by other articles:

				A. B.C. Dang, J. M. Guccione, P. Zhang, A. W. Wallace, R. C. Gorman, J. H. Gorman III, and M. B. Ratcliffe Effect of Ventricular Size and Patch Stiffness in Surgical Anterior Ventricular Restoration: A Finite Element Model Study Ann. Thorac. Surg., January 1, 2005; 79(1): 185 - 193. [Abstract] [Full Text] [PDF]

				M. S. Maurer, D. Spevack, D. Burkhoff, and I. Kronzon Diastolic dysfunction: Can it be diagnosed by Doppler echocardiography? J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1543 - 1549. [Abstract] [Full Text] [PDF]

				D. A. Kass, J. G.F. Bronzwaer, and W. J. Paulus What Mechanisms Underlie Diastolic Dysfunction in Heart Failure? Circ. Res., June 25, 2004; 94(12): 1533 - 1542. [Abstract] [Full Text] [PDF]

				K. Fukamachi, Z. B. Popovic, M. Inoue, K. Doi, S. Schenk, Y. Ootaki, M. W. Kopcak Jr., and P. M. McCarthy Changes in mitral annular and left ventricular dimensions and left ventricular pressure-volume relations after off-pump treatment of mitral regurgitation with the Coapsys device Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 352 - 357. [Abstract] [Full Text] [PDF]

				J. M. Guccione, A. Salahieh, S. M. Moonly, J. Kortsmit, A. W. Wallace, and M. B. Ratcliffe Myosplint decreases wall stress without depressing function in the failing heart: a finite element model study Ann. Thorac. Surg., October 1, 2003; 76(4): 1171 - 1180. [Abstract] [Full Text] [PDF]

				E. N. Simantirakis, G. E. Kochiadakis, K. E. Vardakis, N. E. Igoumenidis, S. I. Chrysostomakis, and P. E. Vardas Left Ventricular Mechanics and Myocardial Blood Flow Following Restoration of Normal Activation Sequence in Paced Patients With Long-term Right Ventricular Apical Stimulation Chest, July 1, 2003; 124(1): 233 - 241. [Abstract] [Full Text] [PDF]

				S. Morita, Y. Ochiai, Y. Tanoue, M. Hisahara, M. Masuda, and H. Yasui Acute volume reduction with aortic valve replacement immediately improves ventricular mechanics in patients with aortic regurgitation J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 283 - 289. [Abstract] [Full Text] [PDF]

				W.-S. Lee, W.-P. Huang, W.-C. Yu, K.-R. Chiou, P. Y.-A. Ding, and C.-H. Chen Estimation of preload recruitable stroke work relationship by a single-beat technique in humans Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H744 - H750. [Abstract] [Full Text] [PDF]

				F. Bauer, M. Jones, T. Shiota, M. S. Firstenberg, J. X. Qin, H. Tsujino, Y. J. Kim, M. Sitges, L. A. Cardon, A. D. Zetts, et al. Left ventricular outflow tract mean systolic acceleration as a surrogatefor the slope of the left ventricular end-systolic pressure-volume relationship J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1320 - 1327. [Abstract] [Full Text] [PDF]

				T. Kondo, Y. Suzuki, T. Kitano, K. Iwai, M. Watanabe, H. Umehara, N. Daido, N. Domae, M. Tashima, T. Uchiyama, et al. Vesnarinone Causes Oxidative Damage by Inhibiting Catalase Function through Ceramide Action in Myeloid Cell Apoptosis Mol. Pharmacol., March 1, 2002; 61(3): 620 - 627. [Abstract] [Full Text] [PDF]

				C.-H. Chen, B. Fetics, E. Nevo, C. E. Rochitte, K.-R. Chiou, P.-A. Ding, M. Kawaguchi, and D. A. Kass Noninvasive single-beat determination of left ventricular end-systolic elastance in humans J. Am. Coll. Cardiol., December 1, 2001; 38(7): 2028 - 2034. [Abstract] [Full Text] [PDF]

				H. Senzaki, B. Fetics, C.-H. Chen, and D. A. Kass Comparison of ventricular pressure relaxation assessments in human heart failure: Quantitative influence on load and drug sensitivity analysis J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1529 - 1536. [Abstract] [Full Text] [PDF]

				F Fantini, G Barletta, A Toso, M Baroni, M Di Donato, M Sabatier, and V Dor Effects of reconstructive surgery for left ventricular anterior aneurysm on ventriculoarterial coupling Heart, February 1, 1999; 81(2): 171 - 176. [Abstract] [Full Text]

				L. M. Semeniuk, I. Belenkie, and J. V. Tyberg Acute Effects of Toborinone on Vascular Capacitance and Conductance in Experimental Heart Failure Circulation, July 7, 1998; 98(1): 58 - 63. [Abstract] [Full Text] [PDF]

				Y. Ochiai, S. Morita, Y. Tanoue, Y. Kawachi, R. Tominaga, and H. Yasui Effects of amrinone, a phosphodiesterase inhibitor, on right ventricular/arterial coupling immediately after cardiac operations J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 139 - 147. [Abstract] [Full Text]

				H. Senzaki, C.-H. Chen, and D. A. Kass Single-Beat Estimation of End-Systolic Pressure-Volume Relation in Humans: A New Method With the Potential for Noninvasive Application Circulation, November 15, 1996; 94(10): 2497 - 2506. [Abstract] [Full Text]